Gout and Stroke: The Hidden Risk Most People Never Hear About

Gout and Stroke: The Hidden Risk Most People Never Hear About

You probably think of gout as a joint problem. Your toe hurts, you take some medicine, you wait for the flare to pass. But what if those uric acid crystals quietly building up in your body were also setting the stage for a stroke?

A 2026 study from Finland tracked nearly 230,000 people with atrial fibrillation (an irregular heart rhythm) over four years. Among those who also had gout, the risk of ischemic stroke (the most common type, caused by a blocked blood vessel to the brain) was 12% higher than in people without gout. And here is the kicker: people with gout who were taking urate-lowering therapy had roughly the same stroke risk as people without gout at all.

That is not a small finding. It means your gout medication might be doing more than protecting your joints. It might be protecting your brain.

What the Finnish Study Actually Found

Published in the journal Stroke in June 2026, the FinACAF study (Finnish Anticoagulation in Atrial Fibrillation) is one of the largest examinations of gout and stroke risk to date (1). The research team pulled data from every patient diagnosed with atrial fibrillation in Finland between 2007 and 2018, which gave them a pool of 229,565 individuals.

Of those, 6,910 had a history of gout. The numbers tell a clear story:

• People with both atrial fibrillation and gout had a 12% higher rate of ischemic stroke compared to those with atrial fibrillation alone.
• For patients not taking blood thinners, the risk jumped to 26% higher.
• Among people with gout who were receiving urate-lowering therapy (ULT), stroke risk dropped by about 30%.
• Only 43% of people with gout in the study were actually taking ULT.

That last number should bother you. More than half of people with gout were not on medication to lower their uric acid, even though doing so appeared to cut their stroke risk significantly.

The researchers noted that the stroke risk from gout was comparable in magnitude to well-established stroke risk factors like diabetes, hypertension, and heart failure. In other words, gout is not a footnote in your medical history. It is a real cardiovascular risk factor.

Why Gout Increases Your Stroke Risk

The connection between gout and stroke comes down to inflammation. When uric acid crystals form in your joints, your immune system reacts. This is not just a local problem in your big toe. The inflammation spreads systemically.

Think of it this way: your body is in a constant low-grade state of alert. Those crystals act like tiny alarms, triggering inflammatory chemicals that circulate throughout your bloodstream. Over time, this chronic inflammation damages blood vessel walls, promotes plaque buildup, and makes your blood more prone to clotting (2).

A Korean study published in Frontiers in Endocrinology found that people with gout had an 11% higher likelihood of stroke compared to those without gout, even after adjusting for age, gender, and other health conditions (3). The data included over 300,000 individuals tracked through a national health insurance database.

A separate Chinese study using data from the China Health and Retirement Longitudinal Study (CHARLS) found that people with hyperuricemia (abnormally high uric acid levels in the blood) had roughly four times the odds of experiencing a stroke compared to those with normal uric acid levels (4). The study also identified physical frailty as a partial mediator, meaning that high uric acid may weaken the body in ways that make stroke more likely.

None of this means gout guarantees a stroke. But the evidence is mounting that untreated or poorly managed gout puts extra stress on your cardiovascular system in ways most people never realize.

The 30% Solution: How Urate-Lowering Therapy Helps

Here is where things get practical. The Finnish study found that people with gout who were on urate-lowering therapy had a 30% lower stroke rate compared to those not treated. In fact, treated patients had stroke risks similar to people without gout at all (1).

This aligns with earlier research from Taiwan, where scientists compared stroke rates between people with gout who were taking ULT and those not taking it. The results were striking: ULT users had roughly half the rate of hospitalized stroke compared to non-users (5).

If you have been on the fence about starting allopurinol or febuxostat, this is another reason to take that step. Lowering your uric acid does more than prevent flares. It may reduce the chronic inflammation that threatens your blood vessels.

You can read more about how these medications compare in our guide on allopurinol versus febuxostat.

Which Medication You Take Might Matter

Not all urate-lowering drugs appear to have the same effect on stroke risk. A 2025 study using the TriNetX research network compared benzbromarone (a uricosuric drug that helps your kidneys excrete uric acid) with allopurinol (a xanthine oxidase inhibitor that reduces uric acid production) (6).

After matching over 26,000 patients in each group, researchers found that benzbromarone users had a 30% higher long-term risk of ischemic stroke compared to allopurinol users. The adjusted hazard ratio was 1.296 (95% CI 1.129 to 1.488, P = 0.0002).

This does not mean benzbromarone is dangerous. It is widely used in Asia and has helped many people. But if you have existing cardiovascular risk factors, the data suggests allopurinol might be the safer choice when it comes to stroke prevention. This is a conversation worth having with your doctor.

What to Do If You Have Gout and Heart Risks

If you have gout alongside other cardiovascular risk factors like high blood pressure, diabetes, or an irregular heartbeat, here is what the research suggests:

Get your uric acid under control. The target for most people with gout is below 6 mg/dL. If you have tophi or frequent flares, the goal is below 5 mg/dL. You can track your numbers using our uric acid levels chart to see where you stand.

Take your medication consistently. The Finnish study showed that adherence matters. People who stuck with their ULT had better outcomes. Skipping doses or stopping because you feel fine leaves the inflammation simmering.

Ask about colchicine. A 2025 study in Lancet Rheumatology found that colchicine, used to prevent gout flares, also reduced cardiovascular events (7). The drug dampens the inflammatory response that drives both gout attacks and blood vessel damage. The Finnish study noted that none of their patients were on colchicine, which may have underestimated the protective effect of gout treatment.

Do not ignore the bigger picture. Gout often travels with other conditions. If you want a broader understanding, our guide on gout and kidney disease explains how these systems interact. When your kidneys struggle to filter uric acid, both your joints and your cardiovascular system pay the price.

Beyond Stroke: Gout’s Other Cardiovascular Connections

Stroke is not the only cardiovascular threat linked to gout. Research has connected gout to heart attacks, heart failure, and atrial fibrillation itself. A Korean nationwide study found that people with gout had a 28% higher likelihood of ischemic heart disease and a 64% higher likelihood of heart failure compared to those without gout (3).

The same inflammatory process that threatens your brain threatens your heart. Uric acid crystals trigger the NLRP3 inflammasome (a protein complex in your immune system that switches on inflammation), which activates inflammatory signals throughout your body. This is the same pathway implicated in atherosclerosis, the buildup of plaque in arteries that leads to heart attacks and strokes.

If you are interested in how gout affects women’s heart health specifically, we covered this topic in detail in our article on gout and women’s heart disease.

Practical Steps You Can Take Today

The good news is that the actions that help your gout also help your cardiovascular system. Here is a short checklist:

1. Know your numbers. Get your serum uric acid tested. If it is above 6 mg/dL and you have had gout flares, talk to your doctor about ULT.
2. Stay on your medication. If you were prescribed allopurinol or febuxostat, take it daily. Do not stop just because you have not had a flare recently.
3. Manage your blood pressure. Some blood pressure medications, like diuretics, can raise uric acid. If you are on a diuretic and have gout, ask if an alternative might work.
4. Keep moving. Gentle exercise like walking helps both joint health and cardiovascular fitness. Our guide on walking and gout covers how to stay active safely.
5. Watch your diet. Limit high-purine foods and alcohol, both of which raise uric acid. You can find specific guidance in our complete gout diet guide.

Gout is often dismissed as a painful nuisance. The evidence says otherwise. If you have gout, you have a cardiovascular risk factor that is treatable. Lowering your uric acid might be one of the most important things you can do for your overall health, not just your joints.

Frequently Asked Questions

Does having gout mean I will have a stroke?

No. Having gout increases your risk, but it does not guarantee a stroke. Many people with gout never experience a stroke. The risk is higher if your gout is untreated or poorly managed. Taking your medication and keeping your uric acid at target levels appears to reduce that risk significantly.

Which is better for stroke prevention: allopurinol or febuxostat?

Both medications lower uric acid effectively. The Finnish study did not directly compare individual ULT drugs for stroke prevention. However, a 2025 TriNetX study found that allopurinol users had lower stroke rates than benzbromarone users. Febuxostat has a 2019 FDA boxed warning regarding cardiovascular safety, though the actual risk is low. Talk to your doctor about which medication is right for your specific situation.

Can lowering uric acid too much cause problems?

Uric acid is not all bad. It acts as an antioxidant in the body, and very low levels (below 3 mg/dL) have been associated with neurodegenerative conditions in some studies. However, for people with gout, the benefits of keeping uric acid below 6 mg/dL far outweigh the risks. Your doctor will help you find the right balance.

Should I ask my doctor about colchicine?

It is worth asking. Colchicine is typically used to prevent gout flares when starting ULT, but research suggests it also reduces cardiovascular inflammation. The 2025 Lancet Rheumatology study showed cardiovascular benefits from colchicine use in people with gout. If you have both gout and cardiovascular risk factors, this could be a good conversation to have with your physician.

Does the Finnish study apply to people without atrial fibrillation?

The FinACAF study specifically looked at people with atrial fibrillation, so the exact percentages may differ for the general population. However, the broader evidence from Korean, Taiwanese, and Chinese studies supports a link between gout and stroke in people without atrial fibrillation as well. The underlying mechanism, chronic inflammation, is the same regardless of whether you have an irregular heartbeat.

Reviewed by the GoutSavvy Editorial Team